Novartis CEO Says Trump Discussed Pricing With Drug CEOs

Novartis CEO Says Trump Discussed Pricing With Drug CEOs


Joseph Jimenez, chief executive officer at Novartis, discusses talks with President Trump including performance based pricing. He speaks with Francine Lacqua on "Bloomberg Surveillance."



from Biotech News